Skip to main content

Table 3 Screening for anti-LUAD/COVID-19 drugs based on cMap

From: Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses

Rank

cMap name

Mean

Number

Enrichment

P-value

1

Puromycin

− 0.729

4

− 0.959

0

2

Emetine

− 0.522

4

− 0.83

0.00151

3

Glycocholic acid

− 0.506

4

− 0.815

0.00211

4

Chicago Sky Blue 6B

− 0.337

4

− 0.797

0.00336

5

Nitrofural

− 0.297

4

− 0.781

0.00462

6

Cephaeline

− 0.36

5

− 0.758

0.00154

7

Pepstatin

− 0.326

4

− 0.711

0.0141

8

Cinoxacin

− 0.569

4

− 0.711

0.01414

9

4-Hydroxyphenazone

− 0.356

5

− 0.702

0.00511

10

Oxymetazoline

− 0.502

4

− 0.702

0.01647

11

Primidone

− 0.347

4

− 0.671

0.02626

12

Lycorine

− 0.34

5

− 0.669

0.00917

13

Parthenolide

− 0.548

4

− 0.661

0.02998

14

Sulindac

− 0.437

7

− 0.654

0.00178

15

Citalopram

− 0.318

4

− 0.642

0.03929

16

N-acetylmuramic acid

− 0.322

4

− 0.64

0.03995

17

Tropine

− 0.357

4

− 0.639

0.04084

18

Ciclosporin

− 0.29

6

− 0.594

0.01577

19

Benzamil

− 0.302

6

− 0.542

0.03665